The relevance of reward pathways for schizophrenia

Current Opinion in Psychiatry

Volumn 23, Issue 2, 2010, Pages 91-96

  Ziauddeen, Hisham ^a   Murray, Graham K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dopamine; Motivation; Psychosis; Reward learning; Salience

Indexed keywords

CANNABINOID; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NORADRENALIN;

ANHEDONIA; BEHAVIOR; CONCEPTUAL FRAMEWORK; DELUSION; DISEASE SEVERITY; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; LIMBIC CORTEX; MOTIVATION; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; PSYCHOSIS; PUNISHMENT; REINFORCEMENT; REVIEW; REWARD; SCHIZOPHRENIA; STRIATE CORTEX; SYMPTOM; TREATMENT OUTCOME;

CUES; HUMANS; LEARNING; MAGNETIC RESONANCE IMAGING; MOTIVATION; NEURAL PATHWAYS; PSYCHOLOGICAL THEORY; REINFORCEMENT (PSYCHOLOGY); REWARD; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 76649103369     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328336661b     Document Type: Review

References (58)

1. Guillin O, Abi-Dargham A, Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007; 78:1-39.
2. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009; 66:13-20.
3. FletcherPC, FrithCD.Perceiving is believing: aBayesian approach toexplaining the positive symptoms of schizophrenia. Nat Rev Neurosci 2009; 10:48-58.
4. Bleuler E. Dementia praecox or the group of schizophrenias. New York: International University Press; 1911/1950.
5. Stein L, Wise CD. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 1971; 171:1032-1036.
6. Miller R. Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses 1976; 2:203-211.
7. McKenna PJ. Pathology, phenomenology and the dopamine hypothesis of schizophrenia. Br J Psychiatry 1987; 151:288-301.
8. Beninger RJ. The slow therapeutic action of antipsychotic drugs. A possible mechanism involving the role of dopamine in incentive learning. In: Simon P, Soubrie P, Widlocher D, editors. Selected models of anxiety, depression and psychosis. Basel: Karger; 1988. pp. 36-51.
9. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160:13-23.
10. Robbins T. Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs. Nature 1976; 264:57-59.
11. Heinz A, Schmidt LG, Reischies FM. Anhedonia in schizophrenic, depressed, or alcohol-dependent patients: neurobiological correlates. Pharmacopsychiatry 1994; 27 (Suppl 1):7-10.
12. Spitzer M. A neurocomputational approach to delusions. Compr Psychiatry 1995; 36:83-105.
13. Crow T. Catecholamine reward pathways and schizophrenia: the mechanism of the antipsychotic effect and the site of the primary disturbance. Fed Proc 1979; 38:2462-2467.
14. Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (Berl) 2008; 199:457-480.
15. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30:194-202.
16. Voorn P, Vanderschuren LJ, Groenewegen HJ, et al. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 2004; 27:468-474.
17. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007; 30:259-288.
18. Zweifel LS, Parker JG, Lobb CJ, et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine- dependent behavior. Proc Natl Acad Sci U S A 2009; 106:7281-7288.
19. Miller R. Major psychosis and dopamine: controversial features and some suggestions. Psychol Med 1984; 14:779-789.
20. Miller R. The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness. Psychopharmacology (Berl) 1987; 92:405-415.
21. Miller R. Striatal dopamine in reward and attention: a system for understanding the symptomatology of acute schizophrenia and mania. Int Rev Neurobiol 1993; 35:161-278.
22. Miller R. A neurodynamic theory of schizophrenia (and related disorders). Morrisville, North Carolina: Lulu; 2008.
23. Lindsley OR, Skinner BF. A method for the experimental analysis of the behavior of psychotic patients. Am Psychol 1954; 9:419-420.
24. Topping GG, O'Connor N. The response of chronic schizophrenics to incentives. Br J Med Psychol 1960; 33:211-214.
25. Gray JA, Feldon J, Rawlins JNP, Smith AD. The neuropsychology of schizophrenia. Behav Brain Sci 1991; 14:1-19.
26. Roiser JP, Stephan KE, den Ouden HE, et al. Do patients with schizophrenia exhibit aberrant salience? Psychol Med 2009; 39:199-209.
27. Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 2007; 93 (1-3):296-303.
28. Gold JM, Waltz JA, Prentice KJ, et al. Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull 2008; 34:835-847.
29. Elliott R, McKenna PJ, Robbins TW, Sahakian BJ. Neuropsychological evidence for frontostriatal dysfunction in schizophrenia. Psychol Med 1995; 25:619-630.
30. Pantelis C, Barnes TR, Nelson HE, et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997; 120 (Pt 10):1823-1843.
31. Leeson VC, Robbins TW, Matheson E, et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 2009; 66:586-593.
32. McKirdy J, Sussmann JE, Hall J, et al. Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med 2009; 39:1289-1293.
33. Murray GK, Cheng F, Clark L, et al. Reinforcement and reversal learning in first-episode psychosis. Schizophr Bull 2008; 34:848-855.
34. Abler B, Erk S, Walter H. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology (Berl) 2007; 191:823-833.
35. Pessiglione M, Seymour B, Flandin G, et al. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442:1042-1045.
36. Murray GK, Clark L, Corlett PR, et al. Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 2008; 8:34.
37. Heerey EA, Gold JM. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J Abnorm Psychol 2007; 116:268-278.
38. Horan WP, Kring AM, Blanchard JJ. Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 2006; 32:259-273.
39. Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Personal 2006; 40:1086-1102.
40. Barch DM. The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know. Schizophr Bull 2005; 31:875-881.
41. Plailly J, d'Amato T, Saoud M, Royet JP. Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. Neuroimage 2006; 29:302-313.
42. Crespo-Facorro B, Paradiso S, Andreasen NC, et al. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. JAMA 2001; 286:427-435.
43. Pizzagalli DA, Holmes AJ, Dillon DG, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009; 166:702-710.
44. Strohle A, Stoy M, Wrase J, et al. Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage 2008; 39:966-972.
45. Nestor L, Hester R, Garavan H. Increased ventral striatal BOLD activity during nondrug reward anticipation in cannabis users. Neuroimage 2009; 49:1133-1143.
46. Beck A, Schlagenhauf F, Wustenberg T, et al. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 2009; 66:734-742.
47. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006; 29:409-416.
48. Schlagenhauf F, Juckel G, Koslowski M, et al. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl) 2008; 196:673-684.
49. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) 2006; 187:222-228.
50. Abler B, Greenhouse I, Ongur D, et al. Abnormal reward system activation in mania. Neuropsychopharmacology 2008; 33:2217-2227.
51. Mizrahi R, Kiang M, Mamo DC, et al. The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophr Res 2006; 88:111-118.
52. Agid O, Kapur S, Arenovich T, Zipursk YRB. Delayed-onset hypothesis of antipsychotic action. A hypothesis tested and rejected. Arch Gen Psychiatry 2003; 60:1228-1235.
53. Jensen J, Willeit M, Zipursky RB, et al. The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 2008; 33:473-479.
54. Murray GK, Corlett PR, Clark L, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008; 13:239; 67-76.
55. Corlett PR, Murray GK, Honey GD, et al. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain 2007; 130 (Pt 9):2387-2400.
56. Waltz JA, Schweitzer JB, Gold JM, et al. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 2009; 34:1567-1577.
57. Schlagenhauf F, Sterzer P, Schmack K, et al. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry 2009; 65:1032-1039.
58. Kegeles L, Frankle WG, Gil R, et al. Schizophrenia is associated with increased synaptic dopamine in associative rather than limbic striatum: implications for mechanism of action of antipsychotic drugs. Schizophr Bull 2007; 33:294.